id doaj-941040870dd743d1996b3bb3e171ab0c
record_format Article
spelling doaj-941040870dd743d1996b3bb3e171ab0c2020-11-25T02:05:19ZengFrontiers Media S.A.Frontiers in Immunology1664-32242019-11-011010.3389/fimmu.2019.02788510225Editorial: Cellular Therapies in CancerHind Rafei0Rohtesh S. Mehta1Katayoun Rezvani2Division of Cancer Medicine, MD Anderson Cancer Center, Houston, TX, United StatesDepartment of Stem Cell Transplant and Cellular Therapy, MD Anderson Cancer Center, Houston, TX, United StatesDepartment of Stem Cell Transplant and Cellular Therapy, MD Anderson Cancer Center, Houston, TX, United Stateshttps://www.frontiersin.org/article/10.3389/fimmu.2019.02788/fullcellular therapychimeric antigen receptor-T cell therapychimeric antigen receptor-natural killer cell therapyadoptive cell therapyT cellsnatural killer cells
collection DOAJ
language English
format Article
sources DOAJ
author Hind Rafei
Rohtesh S. Mehta
Katayoun Rezvani
spellingShingle Hind Rafei
Rohtesh S. Mehta
Katayoun Rezvani
Editorial: Cellular Therapies in Cancer
Frontiers in Immunology
cellular therapy
chimeric antigen receptor-T cell therapy
chimeric antigen receptor-natural killer cell therapy
adoptive cell therapy
T cells
natural killer cells
author_facet Hind Rafei
Rohtesh S. Mehta
Katayoun Rezvani
author_sort Hind Rafei
title Editorial: Cellular Therapies in Cancer
title_short Editorial: Cellular Therapies in Cancer
title_full Editorial: Cellular Therapies in Cancer
title_fullStr Editorial: Cellular Therapies in Cancer
title_full_unstemmed Editorial: Cellular Therapies in Cancer
title_sort editorial: cellular therapies in cancer
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2019-11-01
topic cellular therapy
chimeric antigen receptor-T cell therapy
chimeric antigen receptor-natural killer cell therapy
adoptive cell therapy
T cells
natural killer cells
url https://www.frontiersin.org/article/10.3389/fimmu.2019.02788/full
work_keys_str_mv AT hindrafei editorialcellulartherapiesincancer
AT rohteshsmehta editorialcellulartherapiesincancer
AT katayounrezvani editorialcellulartherapiesincancer
_version_ 1724938733998833664